Aaron Wininger is a Senior Attorney and Schwegman’s Director of China Intellectual Property. Aaron counsels both U.S. and Chinese companies on portfolio development and preparation of their patent applications and office action responses. He has worked with clients in the areas of software, networks (wired and wireless), lasers, medical devices, semiconductors and physics.
Aaron prosecutes both Chinese and U.S. trademarks. He has also drafted and prosecuted hundreds of U.S. and international patent applications in a broad spectrum of areas, including computer hardware and software, the Internet, multimedia distribution systems, computer games, digital and analog circuitry, and semiconductor design and fabrication, to name a few.
Most recently, Aaron has counseled Chinese companies on freedom to operate analyses for their entry into the U.S., represented a U.S. gaming company with operations in China, handling Series A and IP issues in China through to IPO; a U.S. scanning electron microscope company, handling their patent portfolio from incorporation through exit via acquisition, and a U.S. wireless company through acquisition. His knowledge of both the Chinese and American markets allows him to advise his clients as they expand their patent portfolios and look for investors to help the company grow.
Aaron has been in China for more than a decade and is conversational in Mandarin.
Articles in the National Law Review database by Aaron Wininger
Aaron Wininger, Schwegman’s Director of China Intellectual Property law, is a National Law Review Go-To Thought Leader for his contributions focusing on Chinese Intellectual Property Regulation, Legislation, and Litigation. Mr. Wininger’s experience counseling both U.S. and Chinese companies on portfolio development, preparation of patent applications and office action responses and his familiarity with the China National Intellectual Property Administration (CNIPA) adds to his timely analysis of Chinese trademark, patent, and copyright cases and what they mean for companies in both the U.S and in the People’s Republic of China.